GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $512,000 | -2.1% | 11,773 | -2.0% | 0.01% | +16.7% |
| Q1 2022 | $523,000 | -5.4% | 12,017 | -4.2% | 0.01% | 0.0% |
| Q4 2021 | $553,000 | +2.0% | 12,544 | -11.6% | 0.01% | -25.0% |
| Q3 2021 | $542,000 | -6.4% | 14,197 | -1.2% | 0.01% | 0.0% |
| Q2 2021 | $579,000 | +16.0% | 14,364 | +2.8% | 0.01% | -11.1% |
| Q1 2021 | $499,000 | -2.9% | 13,977 | +1.4% | 0.01% | -18.2% |
| Q4 2020 | $514,000 | +72.5% | 13,782 | +76.5% | 0.01% | +37.5% |
| Q3 2020 | $298,000 | +2.8% | 7,810 | +11.3% | 0.01% | -11.1% |
| Q2 2020 | $290,000 | +12.0% | 7,018 | +4.1% | 0.01% | -18.2% |
| Q1 2020 | $259,000 | -24.3% | 6,742 | -6.2% | 0.01% | -21.4% |
| Q4 2019 | $342,000 | +51.3% | 7,185 | +37.1% | 0.01% | +27.3% |
| Q3 2019 | $226,000 | – | 5,240 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |